semaglutide evoke and evoke+: design of two large‐scale, double‐blind, placebo‐controlled, phase 3 studies evaluating the neuroprotective effects of in early Alzheimer's disease - Atri - 2022 - Alzheimer's & Dementia Semaglutide fails to slow cognitive

Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes 2022

Doctor answers your questions on the GLP-1 treatments Dr

5,6 Risk factors to develop anorexia nervosa are a family history of eating disorders, a personal history of psychiatric illness or autoimmune disease and a history of functional symptoms

Lucky, A

Marycz K, Kornicka K, Grzesiak J, mieszek A, Szapka J

Moreover, also a by-product of ethanol metabolism such as acetaldehyde, which is further oxidised to acetate by mitochondrial aldehyde dehydrogenase, seems to contribute primarily to the alcohol-induced liver diseases by acting at the genomic level through up-regulation of some redox-sensitive transcription factors involved in fibrogen-esis, such as AP-1 and NF-B